Listed by the USPTO as BOWLES, DAVID PAUL
Tech Center 1600 • Art Units: 1617 1653 1654 1656
This examiner grants 70% of resolved cases
BOWLES, DAVID PAUL works in tech center 1600 and art unit 1617. The profile covers 46 resolved cases, with a 69.6% allowance rate and a median of 1290 days to allowance. The 28.1% interview lift indicates that interviews are associated with improved allowance outcomes in the measured record.
The leading companies are GEORGIA TECH RESEARCH Corporation, Bristol-Myers Squibb Company, and Rochal Technologies LLC. The listed firms are MARSHALL, GERSTEIN & BORUN LLP, Meunier Carlin & Curfman LLC, and BROWN RUDNICK LLP. The smaller case volume calls for measured interpretation, while the data supports interview preparation and planning for a 1290-day median.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18024871 | METHODS OF USING POLYMERIZED HUMAN SERUM ALBUMIN | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy69.6% of resolved applications examined by David Paul Bowles were allowed (46 resolved cases), compared with 34.1% across Art Unit 1617 over the last five years.
This examiner's interview lift is +28.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by David Paul Bowles took 1,290 days on average from filing to allowance.
David Paul Bowles examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
